AI technologies for detecting diabetic retinopathy

  • Medtech innovation briefing
  • MIB265
  • Published: 
Download (PDF)

Regulatory information

EyeArt and Retmarker are CE marked class IIa medical devices. RetinaLyze is a CE marked class I (self-certified) medical device.